Literature DB >> 12037798

Validity of the depression coping self-efficacy scale.

Sharon Tucker1, Susan Brust, Beverly Richardson.   

Abstract

The purpose of this study was to examine construct validity of the Depression Coping Self-Efficacy Scale (DCSES) among patients receiving inpatient (n = 25) or partial hospital treatment (n = 25) for a depressive disorder. At time of treatment admission and discharge, patients completed the DCSES and Center for Epidemiologic Studies Depression (CES-D) Scale and researchers completed the Derogatis Psychiatric Rating Scale (DPRS) and Global Assessment of Functioning (GAF) Scale. The findings indicated depression coping self-efficacy levels to be related to levels of depressive symptoms and global functioning, particularly through and after treatment, and promise for the DCSES for measuring and targeting nursing interventions. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12037798     DOI: 10.1053/apnu.2002.32949

Source DB:  PubMed          Journal:  Arch Psychiatr Nurs        ISSN: 0883-9417            Impact factor:   2.218


  4 in total

1.  The Self-Efficacy Questionnaire for Depression in Adolescents (SEQ-DA). Development and psychometric evaluation.

Authors:  Bruce Tonge; Neville King; Ester Klimkeit; Glenn Melvin; David Heyne; Michael Gordon
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-10       Impact factor: 4.785

2.  [Development and psychometric properties of the Escala de Autoeficacia para la Depresión en Adolescentes (EADA)].

Authors:  Mirella Díaz-Santos; Eduardo Cumba-Avilés; Guillermo Bernal; Carmen Rivera-Medina
Journal:  Interam J Psychol       Date:  2008

3.  Factor Structure of the Escala de Autoeficacia para la Depresión en Adolescentes (EADA).

Authors:  Mirella Díaz-Santos; Eduardo Cumba-Avilés; Guillermo Bernal; Carmen Rivera-Medina
Journal:  Hisp J Behav Sci       Date:  2011-11-11

4.  Study protocol: to investigate effects of highly specialized rehabilitation for patients with multiple sclerosis. A randomized controlled trial of a personalized, multidisciplinary intervention.

Authors:  Jan Sørensen; Anne Lee; Brita Løvendahl; Michael Nørgaard; Jette Bay; Peter Vestergaard Rasmussen; Finn Boesen
Journal:  BMC Health Serv Res       Date:  2012-09-06       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.